drugset / Trial / NCT04898556

Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain

NCT04898556

Phase 3 Unknown 50 enrolled Dr. Santiago Palacios
RandomizedParallel-groupOpen-labelTreatment

Summary

A prospective, open, randomized and controlled clinical intervention study in women over 45 years of age with a diagnosis of vulvovaginal atrophy (dryness and / or dyspareunia, etc.) and vulvar and / or vestibular pain. The efficacy of Prasterone treatment is evaluated in those patients willing to undergo the treatment compared to the control group.

Timeline

Start
2020-12-22
Primary completion
2021-05-01
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dehydroepiandrosterone Other / unclassified 6.5 mg